Llwytho...
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients. In this regard, global COPD treatment guidelines have recognized the importance of inhaler d...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pulm Ther |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Healthcare
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6967354/ https://ncbi.nlm.nih.gov/pubmed/32026426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-019-0090-1 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|